Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197794 · ClinicalTrials.gov registry record · Phase 2
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,144
- Enrollment target
NCT01197794 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 1,144 participants.
The verdict
NCT01197794, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,144 participants
- Enrollment target
Study Summary
The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.
Interventions
- DRUG Placebo
- DRUG AZD1981
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,144 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197794
The ClinicalTrials.gov registry entry for NCT01197794 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01197794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197794 about?
NCT01197794 is a clinical study titled "Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients". The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.
What is the current status of trial NCT01197794?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,144 participants. The study started on 2010-10. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01197794?
The interventions under investigation include: Placebo (DRUG), AZD1981 (DRUG).
Who is sponsoring clinical trial NCT01197794?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.